Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database-Reference-Cited by-同舟云学术

Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

Published:2015-02-02 Issue:4 Volume:90 Page:E73-E74
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Holmström Morten O.¹,Gimsing Peter²,Abildgaard Niels³,Andersen Niels F.⁴,Helleberg Carsten⁵,Clausen Niels Aage T.¹⁵,Klausen Tobias W.⁵,Frederiksen Mikael⁶,Kristensen Dan L.⁷,Larsen Herdis⁸,Pedersen Per T.⁹,Andersen Kristian Thidemann¹⁰,Pedersen Robert Schou¹¹,Jensen Bo Amdi¹,Gregersen Henrik⁸,Vangsted Annette J.²

Affiliation:

1. Department of Hematology; Roskilde Hospital; Roskilde 4000 Denmark

2. Department of Hematology; Rigshospitalet; Copenhagen 2100 Denmark

3. Department of Hematology; Odense University Hospital; Odense 5000 Denmark

4. Department of Hematology; Aahus University Hospital; Århus 8000 Denmark

5. Department of Hematology; Herlev Hospital; Herlev 2730 Denmark

6. Department of Hematology; Sygehus Sønderjylland; Aabenraa 6200 Denmark

7. Department of Oncology; Naestved Hospital; Naestved 4700 Denmark

8. Department of Hematology; Aalborg University Hospital; 9000 Aalborg Denmark

9. Department of Hematology; Sydvestjysk Sygehus Esbjerg; Esbjerg 6700 Denmark

10. Department of Medicine; Sygehus Lillebaelt Vejle; Vejle 7100 Denmark

11. Department of Hematology and Medicine; Regionshospitalet Holstebro; Holstebro Laegårdvej 7500 Denmark

Funder

Danish Cancer Society

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23932/fullpdf

Reference7 articles.

1. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study;Sant;Lancet Oncol,2014

2. Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party;Augustson;J Clin Oncol,2005

3. Multiple myeloma in octogenarians: Clinical features and outcome in the novel agent era;Dimopoulos;Eur J Haematol,2012

4. Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules;Cesana;Haematologica,2003

5. High early mortality rate in elderly patients with multiple myeloma receiving a vincristine-doxorubicin-dexamethasone regimen;Teng;Am J Hematol,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in China;Hematology;2023-11-29

2. Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2023-10

3. A real‐world data analysis of predictors of early mortality after a diagnosis of multiple myeloma;Cancer;2023-03-29

4. Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors;Biomedicines;2023-03-21

5. Immune responses to COVID‐19 booster vaccinations in intensively anti‐CD38 antibody treated patients with ultra‐high‐risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial;British Journal of Haematology;2023-03-09